Literature DB >> 16545801

Activation and blockade by choline of bovine alpha7 and alpha3beta4 nicotinic receptors expressed in oocytes.

Juana M González-Rubio1, Jonathan Rojo, Laura Tapia, Victoria Maneu, José Mulet, Luis M Valor, Manuel Criado, Francisco Sala, Antonio G García, Luis Gandía.   

Abstract

Choline, the precursor and the metabolite of acetylcholine, is reputed as a selective alpha7 nicotinic receptor agonist. In this study, however, we have seen that choline exerted a dual effect on bovine nicotinic receptors expressed in Xenopus oocytes. On the one hand, choline behaved as a weak full agonist on bovine alpha7-mediated inward currents, with an EC50 of 0.43 mM. On the other, choline blocked bovine alpha3beta4 currents, with an IC50 of 0.97 mM. The blockade by choline was fast (tau(on), 0.36 s), fully reversible (tau(off), 1.23 s), exhibited voltage-dependence (60% blockade at -100 mV and 30% blockade at -40 mV), and was of a non-competitive nature, suggesting an open-channel type of alpha3beta4 receptor blockade. Thus, choline by activating alpha7 receptors and/or blocking alpha3beta4 receptors might play a physiological role in the control of neurotransmission at cholinergic synapses where alpha7 and alpha3beta4 receptor are expressed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545801     DOI: 10.1016/j.ejphar.2006.02.014

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.

Authors:  Geeta Sharma; Sukumar Vijayaraghavan
Journal:  Subst Abuse       Date:  2008-11-11

2.  Heterogeneity of nicotinic acetylcholine receptor expression in the caudal nucleus of the solitary tract.

Authors:  David V Smith; Victor V Uteshev
Journal:  Neuropharmacology       Date:  2007-11-05       Impact factor: 5.250

3.  In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.

Authors:  K Freitas; S S Negus; F I Carroll; M I Damaj
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.